Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ton Lisman

Showing results (161-170 of 362) with videos related to

Pageof 37
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 2, 2018
Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble ThrombomodulinLaura C Burlage, Sarah Bos, Jelle Adelmeijer, et al.
F1000Research|October 9, 2014
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activationFreeha Arshad, Jelle Adelmeijer, Hans Blokzijl, et al.
Plos One|February 21, 2019
Evaluation of hemostasis in patients with end-stage renal diseaseAnja Gäckler, Hana Rohn, Ton Lisman, et al.
Digestive Diseases and Sciences|September 1, 2006
Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?Vinay Sundaram, Abdullah M S Al-Osaimi, Jason J Lewis, et al.
Research and Practice in Thrombosis and Haemostasis|September 18, 2024
Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assaysMarie-Astrid van Dievoet, Karim Zouaoui Boudjeltia, Madeleine Rousseaux, et al.
Research and Practice in Thrombosis and Haemostasis|March 3, 2023
Congruent identification of imbalanced fibrinolysis by 2 distinct clot lysis time assaysEllen G Driever, Julie Brogaard Larsen, Sarah Bos, et al.
Research and Practice in Thrombosis and Haemostasis|December 11, 2023
Patients with metabolic dysfunction-associated steatotic liver disease have preserved <i>in vitro</i> responses to antiplatelet drugsBente P van den Boom, André P van Beek, Jelle Adelmeijer, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver diseaseTon Lisman, Virginia Hernandez-Gea, Maria Magnusson, et al.
Blood|June 10, 2015
Horizontal RNA transfer mediates platelet-induced hepatocyte proliferationMarc Kirschbaum, Golnar Karimian, Jelle Adelmeijer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 6, 2015
Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donorsLaura C Burlage, Shanice A Karangwa, Ton Lisman, et al.
Pageof 37

Showing results (161-170 of 362) with videos related to

Sort By:
Pageof 37
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 2, 2018
Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble ThrombomodulinLaura C Burlage, Sarah Bos, Jelle Adelmeijer, et al.
F1000Research|October 9, 2014
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activationFreeha Arshad, Jelle Adelmeijer, Hans Blokzijl, et al.
Plos One|February 21, 2019
Evaluation of hemostasis in patients with end-stage renal diseaseAnja Gäckler, Hana Rohn, Ton Lisman, et al.
Digestive Diseases and Sciences|September 1, 2006
Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?Vinay Sundaram, Abdullah M S Al-Osaimi, Jason J Lewis, et al.
Research and Practice in Thrombosis and Haemostasis|September 18, 2024
Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assaysMarie-Astrid van Dievoet, Karim Zouaoui Boudjeltia, Madeleine Rousseaux, et al.
Research and Practice in Thrombosis and Haemostasis|March 3, 2023
Congruent identification of imbalanced fibrinolysis by 2 distinct clot lysis time assaysEllen G Driever, Julie Brogaard Larsen, Sarah Bos, et al.
Research and Practice in Thrombosis and Haemostasis|December 11, 2023
Patients with metabolic dysfunction-associated steatotic liver disease have preserved <i>in vitro</i> responses to antiplatelet drugsBente P van den Boom, André P van Beek, Jelle Adelmeijer, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver diseaseTon Lisman, Virginia Hernandez-Gea, Maria Magnusson, et al.
Blood|June 10, 2015
Horizontal RNA transfer mediates platelet-induced hepatocyte proliferationMarc Kirschbaum, Golnar Karimian, Jelle Adelmeijer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 6, 2015
Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donorsLaura C Burlage, Shanice A Karangwa, Ton Lisman, et al.
Pageof 37